Biotech Values

[DewDiligence]

VPHM – An FDA advisory panel voted 16-0 in favor of approving generic versions of Vancocin, which almost assures that such generics will be approved and launched in the next few months:

http://finance.yahoo.com/news/ViroPharma-Announces-Support-prnews-2738604319.html?x=0&.v=1

I would not expect VPHM’s share price to be hit especially hard because most investors presumably anticipated this outcome.